{
  "title": "Mirtazapine for Agitated Behaviors in Dementia",
  "itunes:title": "Mirtazapine for Agitated Behaviors in Dementia",
  "pubDate": "Sun, 04 Sep 2022 16:00:21 +0000",
  "guid": "8c8f602b-aa3b-4e5e-9273-fab385101698",
  "link": "https://psychopharmacology.libsyn.com/mirtazapine-for-agitated-behaviors-in-dementia",
  "itunes:image": "",
  "description": "<p>In this episode, Dr. Phelps discusses a study on the efficacy and safety of mirtazapine for treating agitation in patients with dementia. Would prescribing mirtazapine be worth the risk? </p> <p>Faculty: Jim Phelps, M.D. <br /> Host: Jessica Diaz, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC181\"> <strong>Learn more about our memberships here</strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/quick-take-vol-38-2645?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC181\"> <strong>Earn 0.5 CMEs: Quick Take Vol. 38</strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/study-of-mirtazapine-for-agitated-behaviors-in-dementia-symbad-a-randomised-double-blind-placebo-controlled-trial-2645-5200?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC181\"> <strong>Study of Mirtazapine for Agitated Behaviors in Dementia (SYMBAD): A Randomised, Double-Blind, Placebo-Controlled Trial</strong></a></li> </ul> <p> </p> <p> </p>",
  "content:encoded": "<p>In this episode, Dr. Phelps discusses a study on the efficacy and safety of mirtazapine for treating agitation in patients with dementia. Would prescribing mirtazapine be worth the risk? </p> <p>Faculty: Jim Phelps, M.D.  Host: Jessica Diaz, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC181\"> Learn more about our memberships here</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/quick-take-vol-38-2645?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC181\"> Earn 0.5 CMEs: Quick Take Vol. 38</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/study-of-mirtazapine-for-agitated-behaviors-in-dementia-symbad-a-randomised-double-blind-placebo-controlled-trial-2645-5200?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC181\"> Study of Mirtazapine for Agitated Behaviors in Dementia (SYMBAD): A Randomised, Double-Blind, Placebo-Controlled Trial</a></li> </ul> <p> </p> <p> </p>",
  "enclosure": "",
  "itunes:duration": "10:06",
  "itunes:explicit": false,
  "itunes:keywords": "",
  "itunes:subtitle": "In this episode, Dr. Phelps discusses a study on the efficacy and safety of mirtazapine for treating agitation in patients with dementia. Would prescribing mirtazapine be worth the risk?  Faculty: Jim Phelps, M.D.  Host: Jessica Diaz, M.D.  ...",
  "itunes:episodeType": "full"
}